Bioactive-Enriched Nanovesicles from American Cockroaches Enhance Wound Healing by Promoting Angiogenesis
Source abstract
Abstract
Skin trauma often results from pain, swelling, and scarring and can significantly interfere with daily activities. Extracts from the American cockroach, a rapidly reproducing insect, have been recognized for therapeutic properties in wound management. Traditional extraction methods use solvents such as ethanol to obtain the active compounds, but these methods may compromise the intrinsic biological properties of American cockroach extracts. In this study, we investigated the use of nanovesicles isolated from fresh American cockroaches in skin wound treatment and focused on their biological characteristics and therapeutic efficacy. Fresh and dried American cockroach nanovesicles (F-ACNVs and D-ACNVs, respectively) were procured via ultrahigh-speed centrifugation. We found that F-ACNVs exhibited superior cell proliferation-promoting activity. By employing metabolomics, proteomics, and long noncoding RNA (lncRNA) omics, we identified a rich repertoire of metabolites, proteins, and lncRNAs within F-ACNVs. In vitro and in vivo experiments demonstrated that F-ACNVs significantly enhanced the proliferation and migration of human umbilical vein endothelial cells (HUVECs) and human skin keratinocytes (HACATs) as well as the repair of skin mechanical trauma. These effects may be mediated through the activation of angiogenic signaling pathways. Our research introduces a novel therapeutic strategy for treating skin trauma and offers insight into the medicinal potential of insects such as the American cockroach while emphasizing the importance of preserving the intrinsic biological properties of insects for optimal therapeutic outcomes.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Antimicrobial Peptides and Activities · Insect Utilization and Effects · Silk-based biomaterials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Cancer Research Center, the Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi Engineering Research Center for Translational Cancer Technology
Jiangxi University of Chinese Medicine
Funding
Education Department of Jiangxi Province · Jiangxi University of Traditional Chinese Medicine · Government of Jiangxi Province · Natural Science Foundation of Jiangxi Province · National TCM Characteristic Technology Inheritance Backbone Project
References (31)
Show source-provided references
1. 10.1007/s12325-017-0478-y10.1007/s12325-017-0478-y ↗
2. 10.1038/s41580-024-00715-110.1038/s41580-024-00715-1 ↗
3. 10.1089/wound.2021.003910.1089/wound.2021.0039 ↗
4. 10.7150/ijbs.8043010.7150/ijbs.80430 ↗
5. 10.1186/s13020-019-0259-410.1186/s13020-019-0259-4 ↗
6. 10.3402/jev.v3.2691310.3402/jev.v3.26913 ↗
7. 10.1016/j.tcb.2023.06.00610.1016/j.tcb.2023.06.006 ↗
8. 10.1016/j.phymed.2024.15542810.1016/j.phymed.2024.155428 ↗
9. 10.1186/s12951-022-01421-w10.1186/s12951-022-01421-w ↗
10. 10.2147/IJN.S44890510.2147/IJN.S448905 ↗
11. 10.1002/adma.20220782610.1002/adma.202207826 ↗
12. 10.1083/jcb.20140107210.1083/jcb.201401072 ↗
13. 10.1016/j.celrep.2015.09.05810.1016/j.celrep.2015.09.058 ↗
14. 10.1371/journal.ppat.100676410.1371/journal.ppat.1006764 ↗
15. 10.1016/j.cois.2020.05.01710.1016/j.cois.2020.05.017 ↗
16. 10.1242/jeb.20870210.1242/jeb.208702 ↗
17. 10.1093/molbev/msy01310.1093/molbev/msy013 ↗
18. 10.1038/s41467-018-03281-110.1038/s41467-018-03281-1 ↗
19. 10.1016/j.jep.2023.11674610.1016/j.jep.2023.116746 ↗
20. 10.1186/s13020-019-0259-410.1186/s13020-019-0259-4 ↗
21. 10.1016/j.biopha.2021.11151310.1016/j.biopha.2021.111513 ↗
22. 10.1016/j.biopha.2019.10885810.1016/j.biopha.2019.108858 ↗
23. 10.1016/j.ijbiomac.2020.08.15610.1016/j.ijbiomac.2020.08.156 ↗
24. 10.3390/ijms2019493210.3390/ijms20194932 ↗
25. 10.1021/acsami.3c0363010.1021/acsami.3c03630 ↗
26. 10.1038/srep3299310.1038/srep32993 ↗
27. 10.1016/j.phrs.2021.10574910.1016/j.phrs.2021.105749 ↗
28. 10.1021/acsami.3c0363010.1021/acsami.3c03630 ↗
29. 10.3390/pharmaceutics1103012910.3390/pharmaceutics11030129 ↗
30. 10.3390/ijms1807141910.3390/ijms18071419 ↗
31. 10.1016/j.bioactmat.2021.06.01410.1016/j.bioactmat.2021.06.014 ↗